DJIA 16,351.38 293.03 1.82%
NASDAQ 4,749.98 113.87 2.46%
S&P 500 1,948.86 35.01 1.83%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

51.75 3.00 (6.15%)

REAL-TIME: Last trade at

Extended Hours: $51.85 $0.10 (0.19%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ISIS $51.75 6.15%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $49.05
Previous Close $48.75
Daily Range $48.65 - $51.81
52-Week Range $35.26 - $77.80
Market Cap $6.2B
P/E Ratio 256.58
Dividend (Yield) $0.00 (0.0%)
Volume 1,634,898
Average Daily Volume 1,750,931
Current FY EPS -$0.52

Sector

Healthcare

Industry

Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary

Isis' News-Filled Week

The biotech announces a new partnership, clinical trial results, and earnings over the course of two days.

5 Top BioPharma Stocks That May Have Sold Off Too Much and Become Bargains

3 Promising Biotechs Hobbled By First-Impression Issues

Isis Pharmaceuticals Enters Oversold Territory (ISIS)

Isis Pharmaceuticals Misses on Q2 Earnings and Revenues - Analyst Blog

Isis Pharmaceuticals Misses on Q2 Earnings and Revenues - Analyst Blog

Isis Pharmaceuticals (ISIS) Earnings Report: Q2 2015 Conference Call Transcript

Isis Pharmaceuticals' (ISIS) CEO Stan Crooke on Q2 2015 Results - Earnings Call Transcript

Isis Pharmaceuticals (ISIS) Misses Earnings Estimates in Q2 - Tale of the Tape

Will Isis Pharmaceuticals (ISIS) Beat Q2 Earnings Estimates? - Analyst Blog

Isis Pharma 8-K Filing Shows Company Enters Agreement with Astrazeneca To Discover And Develop Antis

Isis Pharma 8-K Filing Shows Company Enters Agreement with Astrazeneca To Discover And Develop Antisense Drugs FOr Cardiovascular, Metabolic And Renal Disease

See More ISIS News...

ISIS's Top Competitors

ISIS $51.75 (6.15%)
Current stock: ISIS
AMGN $152.29 (3.28%)
Current stock: AMGN
GILD $104.27 (2.74%)
Current stock: GILD
BIIB $304.21 (4.00%)
Current stock: BIIB